Biofarm S.A. (BVB: BIO)
Romania
· Delayed Price · Currency is RON 0.728
0.00 (0.00%)
At close: Dec 20, 2024
Biofarm Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 282.37 | 280.29 | 276.98 | 239.04 | 216.42 | 195.32 | Upgrade
|
| Other Revenue | -0.24 | - | - | - | - | - | Upgrade
|
| Revenue | 282.13 | 280.29 | 276.98 | 239.04 | 216.42 | 195.32 | Upgrade
|
| Revenue Growth (YoY) | -5.18% | 1.19% | 15.87% | 10.45% | 10.80% | 6.02% | Upgrade
|
| Cost of Revenue | 46.19 | 49.98 | 45.69 | 40.44 | 39.64 | 37.12 | Upgrade
|
| Gross Profit | 235.94 | 230.31 | 231.29 | 198.6 | 176.78 | 158.2 | Upgrade
|
| Selling, General & Admin | 103.8 | 109.68 | 105.69 | 90.13 | 82.01 | 75.12 | Upgrade
|
| Other Operating Expenses | 32.64 | 28.86 | 33.14 | 26.29 | 19.98 | 14.08 | Upgrade
|
| Operating Expenses | 153.5 | 155.5 | 154.18 | 129.74 | 113.12 | 97.29 | Upgrade
|
| Operating Income | 82.44 | 74.81 | 77.11 | 68.87 | 63.67 | 60.91 | Upgrade
|
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Interest & Investment Income | 6.68 | 6.88 | 3.14 | 0.88 | 1.18 | 1.58 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.16 | -0.16 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 88.97 | 81.53 | 80.25 | 69.74 | 64.85 | 62.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | - | -0.19 | - | -0.02 | Upgrade
|
| Asset Writedown | 2.44 | 2.44 | 1.84 | - | - | - | Upgrade
|
| Legal Settlements | -0.25 | -0.25 | -1.21 | - | - | - | Upgrade
|
| Pretax Income | 91.15 | 83.71 | 80.88 | 69.55 | 64.85 | 62.47 | Upgrade
|
| Income Tax Expense | 10.83 | 6.7 | 9.96 | 9.2 | 10.58 | 11.59 | Upgrade
|
| Net Income | 80.32 | 77.01 | 70.92 | 60.36 | 54.26 | 50.88 | Upgrade
|
| Net Income to Common | 80.32 | 77.01 | 70.92 | 60.36 | 54.26 | 50.88 | Upgrade
|
| Net Income Growth | 6.90% | 8.60% | 17.50% | 11.22% | 6.65% | 32.42% | Upgrade
|
| Shares Outstanding (Basic) | 985 | 985 | 985 | 985 | 985 | 985 | Upgrade
|
| Shares Outstanding (Diluted) | 1,080 | 1,080 | 1,071 | 1,061 | 1,057 | 1,055 | Upgrade
|
| Shares Change (YoY) | 9.62% | 0.83% | 1.01% | 0.34% | 0.17% | 0.24% | Upgrade
|
| EPS (Basic) | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | Upgrade
|
| EPS Growth | -2.48% | 7.70% | 16.35% | 10.92% | 6.43% | 32.05% | Upgrade
|
| Free Cash Flow | 24.4 | 49.99 | -1.11 | 47.73 | 12.02 | 53.16 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.05 | -0.00 | 0.05 | 0.01 | 0.05 | Upgrade
|
| Dividend Per Share | 0.031 | 0.031 | 0.030 | 0.024 | 0.022 | 0.021 | Upgrade
|
| Dividend Growth | 3.33% | 3.33% | 25.00% | 9.09% | 4.76% | 5.00% | Upgrade
|
| Gross Margin | 83.63% | 82.17% | 83.50% | 83.08% | 81.69% | 80.99% | Upgrade
|
| Operating Margin | 29.22% | 26.69% | 27.84% | 28.81% | 29.42% | 31.18% | Upgrade
|
| Profit Margin | 28.47% | 27.48% | 25.60% | 25.25% | 25.07% | 26.05% | Upgrade
|
| Free Cash Flow Margin | 8.65% | 17.83% | -0.40% | 19.97% | 5.55% | 27.22% | Upgrade
|
| EBITDA | 100.01 | 91.77 | 92.61 | 82.59 | 74.62 | 69.14 | Upgrade
|
| EBITDA Margin | 35.45% | 32.74% | 33.44% | 34.55% | 34.48% | 35.40% | Upgrade
|
| D&A For EBITDA | 17.56 | 16.96 | 15.5 | 13.73 | 10.95 | 8.23 | Upgrade
|
| EBIT | 82.44 | 74.81 | 77.11 | 68.87 | 63.67 | 60.91 | Upgrade
|
| EBIT Margin | 29.22% | 26.69% | 27.84% | 28.81% | 29.42% | 31.18% | Upgrade
|
| Effective Tax Rate | 11.88% | 8.00% | 12.32% | 13.22% | 16.32% | 18.55% | Upgrade
|
| Advertising Expenses | - | 56.87 | 57.89 | 48.38 | 42.18 | 41.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.